Showing 1 - 10 of 164
"Kostenexplosion" im Gesundheitswesen - zwar erklären, aber nicht nachhaltig lösen lassen. Schweizer Wirtschaftsdaten werden zum …
Persistent link: https://www.econbiz.de/10003289359
In a recent paper I argued that Baumol's (1967) model of "unbalanced growth" offers a ready explanation for the observed secular rise in health care expenditure (HCE) in rich countries (HARTWIG 2006). Baumol's model implies that HCE is driven by wage increases in excess of productivity growth. I...
Persistent link: https://www.econbiz.de/10003764083
A large body of both theoretical and empirical literature has affirmed a positive impact of human capital accumulation in the form of health on economic growth. Yet Baumol (1967) has presented a model in which imbalances in productivity growth between a "progressive" (manufacturing) sector and a...
Persistent link: https://www.econbiz.de/10003768974
The share of health care expenditure in GDP rises rapidly in virtually all OECD countries, causing increasing concern among politicians and the general public. Yet, economists have to date failed to reach an agreement on what the main determinants of this development are. This paper revisits...
Persistent link: https://www.econbiz.de/10003348678
In this paper, we address the issue of spurious correlation in the production of health in a systematic way. Spurious correlation entails the risk of linking health status to medical (and nonmedical) inputs when no links exist. This note first presents the bounds testing procedure as a method to...
Persistent link: https://www.econbiz.de/10003909500
In most developed countries drugs are dispensed to patients through physicians and pharmacists. This paper studies the effects of allowing doctors to directly dispense drugs to patients (self-dispensation) on pharmaceutical coverage. We use a Swiss dataset in our empirical analysis because...
Persistent link: https://www.econbiz.de/10011280788
Hartwig (2008) has presented empirical evidence that the difference between real wage growth and productivity growth at the macroeconomic level is a robust explanatory variable for deflated health-care expenditure growth in OECD countries. In this paper, we test whether this finding is robust to...
Persistent link: https://www.econbiz.de/10009565669
Michael Grossman's human capital model of the demand for health has been argued to be one of the major achievements in theoretical health economics. Attempts to test this model empirically have been sparse, however, and with mixed results. These attempts so far relied on using - mostly...
Persistent link: https://www.econbiz.de/10011609992
This paper investigates empirically the impact of diversity on the innovation performance of a firm. We created a measure for diversity that mirrors differences in the resource base of firms within an industry and tested its impact on innovation in addition to more traditional factors like...
Persistent link: https://www.econbiz.de/10003763605
This paper compares quantitative and qualitative data on firm level. The data is taken from two Swiss investment surveys. This has not yet been done in the literature. We will see that the mean change in investment of firms planning to increase (decrease) investments is positive (negative). In...
Persistent link: https://www.econbiz.de/10003763608